Final Program in it's entirety - MyGirlsBlood

Recommendations

Info

Posters, Tuesday and Wednesday Index of Poster Presenters cont’d 29P10 The Year in Review: Describing Prophylaxis and Adherence in Children with Severe Hemophilia A Using Patient Infusion Diaries Bos C, Chan A, Webert K, Almonte T, Decker K, Goldsmith R McMaster Hemophilia Clinic, Hamilton ON, Canada 29P11 Prophylaxis with rFVIIa Three Times a Week for Patients with Severe Hemophilia and Inhibitors: A Single Centre Experience Cermelj M, Gerardo P, Pollola J Department of Haemophilia, Instituto William Osler, CABA, Buenos Aires, Argentina 29P12 Turning Severe into Moderate Hemophilia by Prophylaxis; Are We Reaching Our Goal? den Uijl IEM1,2 , Grobbee DE2 , Fischer K1,2 1Van Creveldkliniek, Dept Haematology, UMC Utrecht, the Netherlands, 2Julius Center for Health Sciences and Primary Care, UMC Utrecht, the Netherlands 29P13 International Study Demonstrates the Benefits of Prophylaxis Collins P1 , Giangrande P2 , Blanchette V3 , Epstein J4 , Xiong Y4 , Li-McLeod J4 1University Hospital of Wales, Cardiff, United Kingdom, 2 3 Churchill Hospital, Oxford, United Kingdom, Hospital for Sick Children, Toronto, ON, Canada, 4Baxter BioScience, Westlake Village, CA, U.S.A. 29P14 Prophylaxis in Hemophilia in Tunisia Gouider E and Meddeb KB Hemophilia Treatment Centre Aziza Othmana Hospital Tunisia, Tunis, Tunisia 29P15 Clotting Factor Concentrates Given to Prevent Bleeding and Bleeding-Related Complications in People with Hemophilia A or B Iorio A1 , Marchesini E1 , Marcucci M1 , Kent S2 1 2 Unversity of Perugia, Perugia, Italy, University of Alberta, Calgary, AB, Canada 29P16 Prophylaxis in Hemophilic Children in Poland Klukowska A, Laguna P, Matysiak M Dept. Pedriatrics, Hematology and Oncology WUM, Warsaw, Poland 82 29P17 Prophylaxis with Novoseven® in Factor VII Deficiency: Preliminary Results from STER (Seven Treatment Evaluation Registry) Auerswald G1, Michaels L, Altisent C., Di Minno G., Dolce A., Napolitano M., Mariani G., on behalf of the STER Study Group 29P18 Comparison of Prophylaxis, On-Demand, or Combined Treatment in 20-35 Year Old Males with Severe Hemophilia in 4 European Countries O’Mahony B, Noone D Irish Haemophilia Society, Dublin, Ireland 29P19 An Economic Model to Evaluate the Cost-Effectiveness of Prophylaxis Regimens on Hemophilia Patients with Inhibitors Knight C1 , Plun-Favreau J2 , Johal S1 1 2 RTI Health Solutions, Zurich, Switzerland, Novo Nordisk, Zurich, Switzerland 29P20 Long-Term FEIBA Prophylaxis in Pediatric Hemophilia A Patients with High-Titer Inhibitors Saxena, K1 , Hawk S2 , Singh P2 , Stevens B2 , and Sexauer C2 1 2 Children’s Hospital, Boston, MA, U.S.A. and University of Oklahoma Children’s Hospital, Oklahoma City, Oklahoma, U.S.A. 29P21 LA-N8, A New Long-Acting Recombinant FVIII with Prolonged Hemostatic Effect in a FeCl3 Induced Injury Model in F8-KO Mice Møller F, Tranholm M, Kjalke M, Thim L, Olsen E, Jespersgaard C Novo Nordisk A/S, Maaloev, Denmark 29P22 LA-N8, A New Long-Acting rFVIII with Prolonged Hemostatic Effect in a Murine Joint Bleeding Model in FVIII-Deficient Mice Øvlisen K, Tranholm M, Olsen E, Kjalke M, Thim L, Stennicke H Novo Nordisk A/S, Maaloev, Denmark PSYCHOSOCIAL ISSUES 30P17 Systemic Family Therapy: An Effective Tool to Manage Hemophiliac’s Family Dynamic Vallin Antunes S1 , dos Reis Tomaz M1 , de Morais Horta A2 1Universidade Federal de São Paulo -Depto Oncologia Clinica e Experimental, 2Universidade Federal de São Paulo, Depto de Enfermagem, Brazil
Index of Poster Presenters cont’d 30P18 Impact of Hemophilia on Family Members in Kenya Abdallah T Kenya Haemophilia Association, Nairobi, Kenya 30P19 Psychopathological and Personality Aspects in Hemophilic Patients: A Preliminary Study in Costa Rica Boza-Calvo C1 , Jensen-Villalobos E1 , Sandoval M2 , Jiménez- Cruz G2 , Salazar-Sanchez L1 1 2 CIHATA-University of Costa Rica, and Hemathology Department, Hospital Mexico, San Jose, Costa Rica 30P20 Hemophilia and Childhood: How to Accompany the Child Cabré P, Grases S, Tarrida C Catalan Association of Haemophilia, Barcelona, Spain 30P21 FUNFILIA - Have Fun and Learn How to Live With Hemophilia Dagnino A Portuguese Hemophilia Society, Lisbon, Portugal 30P22 How to Implement and Develop a Psychology Department Dagnino A Portuguese Hemophilia Society, Lisbon, Portugal 30P23 Achieving More Rapid Treatment Through a High Trust Network D’Ambrosio C1 , Thompson A2 1 2 MyGirlsBlood 501 (C) (3), Mercer Island, WA, U.S.A., Puget Sound Blood Center, Vancouver, WA, U.S.A. 30P24 Psychosocial Involvement in an Emerging Country Duffy A Irish Haemophilia Society, Dublin, Ireland 30P25 Is it Appropriate to Research Men with Hemophilias’ Beliefs and Experiences of Talking about Hemophilia Using a Postal Questionnaire? Dunn N, Griffioen A, Miller R, Yee T Katharine Dormandy Haemophilia & Haemostasis Unit, London, U.K. 30P26 Evaluation of the Efficacy of the Parents Empowering Parents (PEP) Program: A Program for Parents of Children with Bleeding Disorders duTreil S 1 , Rice J 2 , Merritt D 3 , Kuebler E 4 1 Tulane University Medical School / Louisiana Center For Bleeding and Clotting Disorders, and 2 Tulane University School of Public Health / Department of Biostatistics, New Orleans, LA, U.S.A. 3 Children’s Hospital of Michigan / Hemostatis Thrombosis Treatment Center, Detroit, MI, U.S.A. 4 University of Texas in Houston / Gulf States Hemophilia and Thrombophilia Center, Houston, Texas, U.S.A. 30P27 The Saga of Contaminated Blood Products in Iran Ghavidel A, Tabatabaey A Iranian Hemophilia Society, Mashad, Iran 30P28 Building Bridges: PEP in Israel Goldstein G1 , Bashari D, Avni D, Kennet G National Hemophilia Center, Tel Hashomer, Israel 30P29 Suicide Among Males with Hemophilia in the US, 1998-2007 Gomperts E1 , Holtz J1 , Baker J3 , Geraghty S4 , Hudson M5 , Karp S6 , Osip J7 , Presley R2 1Children’s Hospital Los Angeles, Los Angeles, CA, U.S.A., 2Centers for Disease Control and Prevention, Atlanta, GA, U.S.A., 3University of California Los Angeles, Los Angeles, CA, U.S.A., 4Mountain States Hemophilia Center, Aurora, CO, U.S.A., 5Vanderbilt University Medical Center, Nashville, TN, U.S.A., 6UC San Francisco, San Francisco, CA, U.S.A., 7Center for Bleeding and Clotting Disorders, Minneapolis, MN, U.S.A. 30P30 Liver Transplant: A New Experience in the Treatment of Hemophiliacs: Related Psychological Aspects Grases S, Cabré P, Tarrida C Catalan Association of Haemophilia, Barcelona, Spain 30P31 Hemophilia: The Role of Psychology Directed to Low Income Mothers in the Discovery of Capable and Productive Women Hanashiro R Centro Dos Hemofílicos Do Estado De São Paulo– CHESP, São Paulo, Brazil 83 Posters, Tuesday and Wednesday
Page 1 and 2:
Hemophilia Saturday, July 10 - Wedn
Page 3 and 4:
Pre-Congress Sessions cont’d 10:3
Page 5 and 6:
Pre-Congress Sessions cont’d 15:0
Page 7 and 8:
Congress Sessions cont’d S1.6 - M
Page 9 and 10:
Congress Sessions cont’d S2.5 - M
Page 11 and 12:
Congress Sessions cont’d n Long T
Page 13 and 14:
Congress Sessions cont’d M2.4 - M
Page 15 and 16:
Congress Sessions cont’d Tuesday,
Page 17 and 18: Congress Sessions cont’d 14:15 -
Page 19 and 20: Congress Sessions cont’d T3.4 - M
Page 21 and 22: Congress Sessions cont’d n Inhibi
Page 23 and 24: Congress Sessions cont’d W2.4 - L
Page 25 and 26: Index of Speakers cont’d Halimeh,
Page 27 and 28: Index of Poster Presenters Sunday a
Page 29 and 30: Index of Poster Presenters cont’d
Page 67: Index of Poster Presenters cont’d
show all

Final Program in it's entirety - MyGirlsBlood

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?